Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jun 9;59(6):2200264.
doi: 10.1183/13993003.00264-2022. Print 2022 Jun.

International consensus statement on quality standards for managing children/adolescents with bronchiectasis from the ERS CRC Child-BEAR-Net

Affiliations
Free article
Editorial

International consensus statement on quality standards for managing children/adolescents with bronchiectasis from the ERS CRC Child-BEAR-Net

Anne B Chang et al. Eur Respir J. .
Free article
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: E. Alexopoulou, A. Bush, A.J. Collaro, C. Constant, K. Douros, R. Fortescue, M. Griese, K. Grimwood, A. Hector, A.T. Hill, A. Kantar, B. Karadag, O. Mazulov, F. Midulla, A. Moeller, Z. Powell, M. Proesmans, C. Wilson, S.T. Yerkovich and A. Zacharasiewicz have nothing to disclose. A.B. Chang reports grants from the National Health and Medical Research Council, Australia, during the conduct of the study; is an IDMC member for an unlicensed vaccine (GSK) and an unlicensed monoclonal antibody (AstraZeneca); is an advisory member of study design for an unlicensed molecule for chronic cough (Merck); and reports personal fees from being an author of two UpToDate chapters, all outside the submitted work. J. Boyd is an employee of the European Lung Foundation. J.D. Chalmers reports grants and personal fees from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline and Insmed, personal fees from Chiesi, Novartis and Zambon, and grants from Gilead Sciences, outside the submitted work. J. Grigg reports grants and personal fees from OM Pharma, and personal fees from GSK, Novartis, Omron and AstraZeneca, outside the submitted work.

Publication types

LinkOut - more resources